Pinnacle Ventures’ pharmacogenomics future for general practices

This story has been changed to remove reference to a database for information on patient cohorts such as Māori and Pasifika. Pinnacle Ventures says no such database is being built. We apologise for the error.
+Print Archive
Business

Pinnacle Ventures’ pharmacogenomics future for general practices

DNA strand
The PGx test focuses on eight gene areas that indicate how a person metabolises 60 –70 per cent of the medications available in New Zealand
A world-first DNA-testing ser­vice is giving New Zealand patients a road map for avoiding adverse reactions to medica­tions. Called PGx, the pharma